S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Nscale Secures $900 Million Credit Line to Expand AI Infrastructure

London-based Nscale has finalized a $900 million revolving credit facility, a move designed to fast-track the development of its AI data center network. This infusion of capital targets aggressive expansion across the United States, Europe, and the Asia-Pacific region to meet the rising demand for high-performance computing power.

Nscale Secures $900 Million Credit Line to Expand AI Infrastructure
Photo: Bio & News

The credit facility represents a significant vote of confidence from a diverse syndicate of major global financial institutions, including J.P. Morgan, Goldman Sachs, and Morgan Stanley. Other participants include MUFG, RBC Capital Markets, Bank of America, Crédit Agricole CIB, Deutsche Bank, Mizuho, SMBC, TD Securities, and KeyBank N.A. This backing allows the company to deploy capital with greater speed as it constructs the physical foundation required for modern AI training and inference.

Josh Payne, CEO and founder of Nscale, noted that the agreement validates the company’s platform and its strategic focus on vertical integration. By combining software, specialized compute, and power resources, the firm aims to support the infrastructure needs of large-scale technology enterprises. This liquidity provides the necessary flexibility to scale operations globally while maintaining the resource-intensive hardware environments essential for superintelligence projects.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!